SHSE:688068 (China)
Â
Class A
Â¥
123.22
-8.32 (-6.33%)
Jul 22
Business Description
Beijing Hotgen Biotech Co Ltd
ISIN : CNE100003P82
Share Class Description:
SHSE:688068: Class ATotal Employee Number:
946Compare
Compare
Traded in other countries / regions
688068.China Index Membership
SSE Composite Index IPO Date
2019-09-30Description
Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 316.18 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 15.59 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50.5 | |||||
3-Year Book Growth Rate | -9.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 20.79 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.14 | |||||
9-Day RSI | 61.2 | |||||
14-Day RSI | 62.04 | |||||
3-1 Month Momentum % | -32.49 | |||||
6-1 Month Momentum % | -49.14 | |||||
12-1 Month Momentum % | -59.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.74 | |||||
Quick Ratio | 6.47 | |||||
Cash Ratio | 5.5 | |||||
Days Inventory | 159.47 | |||||
Days Sales Outstanding | 102.32 | |||||
Days Payable | 279.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -0.1 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.66 | |||||
Operating Margin % | -65.98 | |||||
Net Margin % | -57.69 | |||||
EBITDA Margin % | -69.82 | |||||
FCF Margin % | -44.39 | |||||
OCF Margin % | -31.32 | |||||
ROE % | -8.96 | |||||
ROA % | -7.71 | |||||
ROIC % | -13.26 | |||||
3-Year ROIIC % | 242.32 | |||||
ROC (Joel Greenblatt) % | -23.86 | |||||
ROCE % | -10.16 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 36.67 | |||||
PS Ratio | 25.48 | |||||
PB Ratio | 4.75 | |||||
Price-to-Tangible-Book | 4.79 | |||||
EV-to-EBIT | -34.08 | |||||
EV-to-EBITDA | -34.08 | |||||
EV-to-Revenue | 23.79 | |||||
EV-to-FCF | -53.59 | |||||
Price-to-GF-Value | 3.43 | |||||
Price-to-Projected-FCF | 2.35 | |||||
| Price-to-Net-Current-Asset-Value | 13.81 | |||||
| Price-to-Net-Cash | 20.64 | |||||
Earnings Yield (Greenblatt) % | -2.9 | |||||
FCF Yield % | -1.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Hotgen Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 427.661 | ||
| EPS (TTM) (Â¥) | -2.84 | ||
| Beta | 1.072 | ||
| 3-Year Sharpe Ratio | 0.57 | ||
| 3-Year Sortino Ratio | 1.29 | ||
| Volatility % | 55.29 | ||
| 14-Day RSI | 62.04 | ||
| 14-Day ATR (Â¥) | 12.869346 | ||
| 20-Day SMA (Â¥) | 113.665 | ||
| 12-1 Month Momentum % | -59.58 | ||
| 52-Week Range (Â¥) | 73.44 - 262.22 | ||
| Shares Outstanding (Mil) | 92.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Hotgen Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Hotgen Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 1.48:1 Stock Split | 2022-06-16 | 87.51 (+0.56%) |
Show
Entries
Beijing Hotgen Biotech Co Ltd Frequently Asked Questions
What is Beijing Hotgen Biotech Co Ltd(SHSE:688068)'s stock price today?
The current price of SHSE:688068 is ¥123.22. The 52 week high of SHSE:688068 is ¥262.22 and 52 week low is ¥73.44.
When is next earnings date of Beijing Hotgen Biotech Co Ltd(SHSE:688068)?
The next earnings date of Beijing Hotgen Biotech Co Ltd(SHSE:688068) is .
Does Beijing Hotgen Biotech Co Ltd(SHSE:688068) pay dividends? If so, how much?
Beijing Hotgen Biotech Co Ltd(SHSE:688068) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval | 2025-03-24 |
Articles on Beijing Hotgen Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers